NACDS Voices Support for Senate Vote on Drug Importation Amendment

Kate H. Gamble, Senior Editor
Published Online: Friday, October 21, 2011
Follow Pharmacy_Times:
National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson, IOM, CAE, issued a statement following the US Senate’s 55-45 vote to defeat an amendment that would have prohibited the FDA from preventing individuals from importing prescription drugs.

“Given that consumer safety cannot be ensured under a prescription drug reimportation system, and that such a system would reduce patients’ access to professional services of their local licensed pharmacists, the Senate made the right decision,” said Anderson. “NACDS appreciates the genuine interest in reducing healthcare expenses that is a motivating factor behind this amendment, and NACDS remains committed to working with all branches and all levels of government, as well as private payers, to improve patient health and reduce costs.”

In addition to concerns regarding the safety and effectiveness of imported drugs, Anderson also pointed out that individuals who obtain medications through personal importation are less likely to benefit from the professional services of their local pharmacist.

“Community pharmacy offers many viable solutions that make prescriptions more affordable and that help to reduce overall healthcare costs,” he said. “These include generic drug utilization, medication therapy management that fosters proper use of medications, screenings, health education, vaccinations, and more.”
Anderson also expressed concerns that Senate Amendment 769 would contribute to the growing problem of illegal Internet drug sellers.

“These sites often ship unapproved, counterfeit, mislabeled, or adulterated products presenting serious health and safety concerns,” the letter stated. Instead of pursuing importation as a method of reducing drug expenditures, NACDS is urging the Senate to consider policies to support cost-saving alternatives, such as the Medication Therapy Management Empowerment Act (S. 274), which would improve access to MTM services for seniors in Medicare Part D, helping reduce the costs associated with medication non-compliance, and the Affordable Medicines Utilization Act (S.1356), which would encourage states to increase generic dispensing rates in their Medicaid programs.

The Senate’s action occurred during consideration of the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill.

To read the letter that NACDS issued, click here.



Related Articles
Kelli Kovak, industry expert on the pharmacy benefit manager industry and health care network designs, gives her perspective on how new health networks will benefit the business of pharmacy, how this will impact on patient choice, and how private pharmacies can stay connected and competitive.
This weekly video program highlights the latest in pharmacy news, product approvals, FDA rulings, and more.
The dean of the University of Oklahoma College of Pharmacy has 3 main pieces of advice for pharmacy students: show gratitude, be on the lookout for new opportunities, and never say never.
Why is there still a big divide on whether a residency can benefit a pharmacy career?
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$